Super MIC B Vitamin – Premium Injection-Grade Nutrient Blend

Our Super MIC B Vitamin formula is a lab-verified, high-potency blend designed for clinical use and advanced supplementation protocols. This meticulously balanced formula includes essential B vitamins, amino acids, and metabolic cofactors to support energy metabolism, liver health, and neurological function.

Each bottle is tested by AZLAB using advanced LCMS and HPLC methods, ensuring purity, accuracy, and compliance with industry standards. It is ideal for use in weight management clinics, anti-aging practices, and wellness centers seeking pharmaceutical-grade ingredients with traceable lab certification.

Clinically Tested Ingredients per Serving:

Trusted by healthcare professionals, this formula supports enhanced fat metabolism, liver detoxification, and cognitive function.

2. Introduction

High-Potency MIC+B Complex Verified by AZLAB

PeptideGurus presents Super MIC B Vitamin, a comprehensive blend of metabolic cofactors designed for professional use. Backed by LCMS and HPLC testing, every batch ensures precise dosing and quality, suitable for injection-based wellness therapies.

3. Description for SEO Purposes

Super MIC B Vitamin is a pharmaceutical-grade injectable formula combining Methionine, Inositol, Choline, and essential B vitamins. Lab-tested by AZLAB using LCMS and HPLC, it supports energy metabolism, liver detox, and nervous system health. Ideal for clinics, wellness providers, and B2B buyers looking for traceable, tested, and high-purity vitamin blends.

4. Keywords

MIC injection, B complex injection, methionine inositol choline, injection-grade vitamins, vitamin B5 B6 B12 injectable, l-carnitine injection, liver detox injection, fat burning injection, tested vitamin ampoule, pharmaceutical grade B vitamins, LCMS tested vitamins, lab verified injectable blend, methylcobalamin injectable, wellness clinic supplies

Bacteriostatic Water

Overview

Retatrutide (10 mg) is a next-generation multi-receptor metabolic research peptide that represents the forefront of peptide innovation for obesity and glucose-metabolism research.
Engineered as a triple agonist, Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors — three of the most important signaling pathways governing energy homeostasis, fat oxidation, and insulin regulation.

By combining the mechanisms of these three receptor families, Retatrutide enables researchers to study a holistic metabolic response that extends beyond single-target peptides. Early studies suggest this peptide’s triple-agonist design results in superior lipid mobilization, enhanced thermogenesis, reduced appetite signals, and improved glycemic control.

Each vial contains 10 mg of high-purity lyophilized Retatrutide, synthesized under controlled conditions and verified by third-party Janoshik laboratory analysis to ensure molecular accuracy and purity above 98%. This product is provided for research use only and is not approved for human or veterinary applications.

Scientific Background

Retatrutide’s development marks a paradigm shift in the peptide-research landscape. While earlier incretin-mimetic peptides such as GLP-1 agonists (e.g., semaglutide) demonstrated notable improvements in appetite control and glycemic management, their effects plateaued due to receptor-specific limitations.

Retatrutide was designed to overcome this bottleneck by engaging:

  • GLP-1 receptors, promoting satiety and delayed gastric emptying.

  • GIP receptors, enhancing insulin sensitivity and anabolic metabolism.

  • Glucagon receptors, stimulating energy expenditure and fat oxidation.

This triple receptor synergy creates a more balanced anabolic-catabolic interplay, providing a comprehensive research model for studying systemic metabolic health, obesity reduction, mitochondrial efficiency, and hormonal cross-talk.

Researchers have reported Retatrutide’s potential relevance to:

  • Weight-management studies, modeling significant body-fat reduction.

  • Glucose homeostasis research, focusing on improved insulin signaling.

  • Lipid metabolism, investigating the acceleration of hepatic and peripheral fat oxidation.

  • Energy-balance and appetite regulation, via central and peripheral signaling pathways.

As such, Retatrutide is being recognized as a next-generation standard for exploring metabolic multi-agonists.

Key Advantages

  • Triple receptor activation – GLP-1, GIP, and glucagon synergy.

  • Advanced weight-management model – simulates real-world metabolic responses.

  • High-purity peptide – >98% purity, Janoshik-certified.

  • Stable lyophilized format – optimized for long-term laboratory storage.

  • Ideal for metabolic, anti-obesity, and endocrinological studies.

Packaging & Quality Control

Each vial of Retatrutide 10 mg is sealed under aseptic conditions using high-grade glass vials to preserve peptide stability.
Every production batch is accompanied by a Certificate of Analysis (COA) detailing HPLC and MS results confirming sequence integrity and purity.

All products are maintained in temperature-controlled storage facilities within our U.S.-based warehouse, allowing fast and compliant domestic shipping to qualified research institutions, laboratories, and distributors.

Storage & Handling

  • Store unopened vials at −20 °C in a dark, dry environment.

  • Once reconstituted, keep between 2–8 °C and use within a short research window.

  • Avoid repeated freeze-thaw cycles.

  • For laboratory research only; not for human or veterinary administration.

SEO Meta Description

Retatrutide 10 mg is a high-purity triple-agonist research peptide targeting GLP-1, GIP, and glucagon receptors for metabolic, obesity, and glucose-control studies. Janoshik verified; ships from U.S. warehouse.

SEO Keywords (Comma-Separated)

Retatrutide 10 mg, Retatrutide peptide, Retatrutide research peptide, GLP-1 GIP glucagon agonist, triple-agonist peptide, metabolic research peptide, weight-management peptide, obesity-research compound, peptide for glucose control, fat-oxidation peptide, energy-balance peptide, Janoshik-tested peptide, peptide for scientific research, Retatrutide USA stock

Bacteriostatic Water

Overview

Retatrutide (20 mg) is a next-generation multi-receptor metabolic research peptide that represents the forefront of peptide innovation for obesity and glucose-metabolism research.
Engineered as a triple agonist, Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors — three of the most important signaling pathways governing energy homeostasis, fat oxidation, and insulin regulation.

By combining the mechanisms of these three receptor families, Retatrutide enables researchers to study a holistic metabolic response that extends beyond single-target peptides. Early studies suggest this peptide’s triple-agonist design results in superior lipid mobilization, enhanced thermogenesis, reduced appetite signals, and improved glycemic control.

Each vial contains 10 mg of high-purity lyophilized Retatrutide, synthesized under controlled conditions and verified by third-party Janoshik laboratory analysis to ensure molecular accuracy and purity above 98%. This product is provided for research use only and is not approved for human or veterinary applications.

Scientific Background

Retatrutide’s development marks a paradigm shift in the peptide-research landscape. While earlier incretin-mimetic peptides such as GLP-1 agonists (e.g., semaglutide) demonstrated notable improvements in appetite control and glycemic management, their effects plateaued due to receptor-specific limitations.

Retatrutide was designed to overcome this bottleneck by engaging:

  • GLP-1 receptors, promoting satiety and delayed gastric emptying.

  • GIP receptors, enhancing insulin sensitivity and anabolic metabolism.

  • Glucagon receptors, stimulating energy expenditure and fat oxidation.

This triple receptor synergy creates a more balanced anabolic-catabolic interplay, providing a comprehensive research model for studying systemic metabolic health, obesity reduction, mitochondrial efficiency, and hormonal cross-talk.

Researchers have reported Retatrutide’s potential relevance to:

  • Weight-management studies, modeling significant body-fat reduction.

  • Glucose homeostasis research, focusing on improved insulin signaling.

  • Lipid metabolism, investigating the acceleration of hepatic and peripheral fat oxidation.

  • Energy-balance and appetite regulation, via central and peripheral signaling pathways.

As such, Retatrutide is being recognized as a next-generation standard for exploring metabolic multi-agonists.

Key Advantages

  • Triple receptor activation – GLP-1, GIP, and glucagon synergy.

  • Advanced weight-management model – simulates real-world metabolic responses.

  • High-purity peptide – >98% purity, Janoshik-certified.

  • Stable lyophilized format – optimized for long-term laboratory storage.

  • Ideal for metabolic, anti-obesity, and endocrinological studies.

Packaging & Quality Control

Each vial of Retatrutide 10 mg is sealed under aseptic conditions using high-grade glass vials to preserve peptide stability.
Every production batch is accompanied by a Certificate of Analysis (COA) detailing HPLC and MS results confirming sequence integrity and purity.

All products are maintained in temperature-controlled storage facilities within our U.S.-based warehouse, allowing fast and compliant domestic shipping to qualified research institutions, laboratories, and distributors.

Storage & Handling

  • Store unopened vials at −20 °C in a dark, dry environment.

  • Once reconstituted, keep between 2–8 °C and use within a short research window.

  • Avoid repeated freeze-thaw cycles.

  • For laboratory research only; not for human or veterinary administration.

SEO Meta Description

Retatrutide 10 mg is a high-purity triple-agonist research peptide targeting GLP-1, GIP, and glucagon receptors for metabolic, obesity, and glucose-control studies. Janoshik verified; ships from U.S. warehouse.

SEO Keywords (Comma-Separated)

Retatrutide 10 mg, Retatrutide peptide, Retatrutide research peptide, GLP-1 GIP glucagon agonist, triple-agonist peptide, metabolic research peptide, weight-management peptide, obesity-research compound, peptide for glucose control, fat-oxidation peptide, energy-balance peptide, Janoshik-tested peptide, peptide for scientific research, Retatrutide USA stock

Free (1) 30 ml Bacteriostatic Water
with qualified orders over $500 USD.
(excludes capsule products, cosmetic peptides, promo codes and shipping)

GLOW (BPC-157 + TB500 + GHK-Cu): Premium Triple Peptide Synergy for Advanced Research

GLOW is a high-potency, triple-action regenerative peptide formulation combining three of the most widely researched peptides in tissue repair, inflammation modulation, and cellular rejuvenation:

  • BPC-157 – 10mg

  • TB-500 – 10mg

  • GHK-Cu – 50mg

Designed for researchers, formulation developers, performance clinics, and regenerative medicine distributors, GLOW provides enhanced synergy by integrating angiogenesis activation, collagen synthesis stimulation, and anti-inflammatory response modulation into one unified research compound.

This blend is produced under strict quality systems with HPLC purity verification, mass balance testing, and low-endotoxin manufacturing protocols, making it suitable for organizations seeking high-stability peptides with dependable batch-to-batch consistency.

Triple-Mechanism Regenerative Synergy

GLOW is engineered to deliver maximum regenerative output by combining three complementary peptide pathways:

🔹 BPC-157 (10mg)

Known for its role in tissue repair, angiogenic response, cellular migration, and gastrointestinal protection. Widely investigated for:

  • Soft tissue recovery

  • Micro-circulation support

  • Accelerated fibroblast activity

  • Anti-inflammatory regulation

🔹 TB-500 (10mg)

A synthetic fragment of thymosin beta-4, used in research for:

  • Actin upregulation

  • Tissue regeneration

  • Wound repair models

  • Cellular mobility enhancement

Its combination with BPC-157 creates a complementary dual-repair pathway favored in advanced regeneration studies.

🔹 GHK-Cu (50mg)

A copper-binding tripeptide known for:

  • Collagen & ECM synthesis stimulation

  • Dermal remodeling

  • Anti-oxidative activity

  • Hair follicle regeneration models

  • Skin tightening & rejuvenation research

The higher 50mg concentration in GLOW enhances cosmetic, dermatology, and anti-aging research applications.

ARA-290 10MG – Research Grade Peptide

ARA-290 is a synthetic peptide studied for its role in inflammation modulation, tissue protection, and cellular stress response research. It has gained attention in neurological, metabolic, and regenerative research programs due to its targeted peptide structure.

Our ARA-290 10mg is supplied with high purity and precise peptide composition, ensuring stable and repeatable research outcomes. Each vial is carefully packaged to protect against moisture, light, and temperature fluctuations during transportation and storage.

ARA-290 is suitable for advanced research institutions and distributors involved in inflammation, neurobiology, and tissue-protection studies.

ARA-290 is a peptide derivative of erythropoietin (EPO) that has shown significant promise in decreasing inflammatory pathways and enhancing repair mechanisms through its action on the innate repair receptors. This peptide, also known as cibinetide, has demonstrated various beneficial effects in clinical research, including reducing HbA1c levels, improving cholesterol profiles, modulating neuropathic pain, and accelerating wound healing.

Product Usage: ARA-290 is strictly intended for use as a research chemical. It is designated for in vitro testing and laboratory experimentation only. Introduction into humans or animals is prohibited by law, and it should only be handled by licensed, qualified professionals. This product is not approved as a drug, food, or cosmetic.

Introduction
ARA-290 is a synthetic variant of the helix beta domain of erythropoietin, designed to harness the neuroprotective and analgesic effects of EPO without promoting red blood cell production. This peptide has progressed through phase II clinical trials and is preparing for phase III trials targeting several applications, including diabetes management and autoimmune sarcoidosis.

Comprehensive Overview and Research Applications
Neuroprotection and Neuropathic Pain
ARA-290 has emerged as a potent neuroprotective agent, offering significant benefits in diabetic neuropathy and potentially other neurodegenerative conditions. Unlike traditional erythropoietin, which can lead to excessive red blood cell production, ARA-290 targets only the protective pathways, alleviating pain without the associated hematologic risks.

Cardiovascular and Vascular Health
ARA-290’s effects extend to cardiovascular health, particularly in protecting against retinal ischemia—a common cause of blindness. By safeguarding endothelial cells and promoting their regeneration, ARA-290 could significantly reduce the burden of vascular diseases. Additionally, its ability to enhance the survival and function of endothelial colony-forming cells could revolutionize treatments for vascular injuries and ischemic conditions.

Inflammation and Immune Modulation
The peptide’s role in reducing inflammatory cytokines and modulating the immune response has implications for transplant medicine, particularly in the survival of transplanted islet cells for diabetes treatment. By inhibiting macrophage activation and cytokine production, ARA-290 could improve the outcomes of cellular transplants and reduce the incidence of rejection.

Tissue Protection and Wound Healing
ARA-290 has shown potential in speeding up the wound healing process, particularly in chronic conditions like diabetes, where slow healing leads to complications. Its ability to stimulate tissue repair and reduce scarring could make it a valuable asset in managing and treating skin injuries and surgical wounds.

ABOUT US

PeptideGurus is a leading supplier of American-made research peptides, offering top-quality products at competitive prices. With a focus on excellence and customer service, they ensure a secure and convenient ordering process with global shipping.

PRODUCTS

Request a Quote

  • Peptide Gurus
    • info@peptidegurus.com
  • Glendale, AZ, USA

    • CONTACT

    Request Inquery